| Dr Candice M Rohr, MD | |
|
330 S Garden Way, Ste 150, Eugene, OR 97401-8176 | |
| (541) 485-0316 | |
| (541) 431-0317 |
| Full Name | Dr Candice M Rohr |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology - Allergy |
| Location | 330 S Garden Way, Eugene, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326084344 | NPI | - | NPPES |
| 239681 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | MD11376 (Oregon) | Primary |
| Entity Name | Allergy & Asthma Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205998663 PECOS PAC ID: 0840286928 Enrollment ID: O20040423000211 |
News Archive
Like the general public, health care professionals may hold certain stereotypes regarding sexual activity and childbearing among women with disabilities. But a new study finds that women with chronic physical disabilities are about as likely as nondisabled women to say they are currently pregnant, after age and other sociodemographic factors are taken into account.
The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. A Massachusetts General Hospital team reports in the American Journal of Preventive Medicine that the previously reported changes in the proportions of more and less healthy foods purchased in the months after their program began have persisted up to two years after the labeling intervention was introduced.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A panel of experts convened by the RAND Corporation has recommended actions that communities around the United States should take to be better prepared to deal with bioterrorist attacks, pandemic flu outbreak and other large-scale public health emergencies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Candice M Rohr, MD 330 S Garden Way, Ste 150, Eugene, OR 97401-8176 Ph: (541) 485-0316 | Dr Candice M Rohr, MD 330 S Garden Way, Ste 150, Eugene, OR 97401-8176 Ph: (541) 485-0316 |
News Archive
Like the general public, health care professionals may hold certain stereotypes regarding sexual activity and childbearing among women with disabilities. But a new study finds that women with chronic physical disabilities are about as likely as nondisabled women to say they are currently pregnant, after age and other sociodemographic factors are taken into account.
The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice of more healthful food items among customers in a large hospital cafeteria. A Massachusetts General Hospital team reports in the American Journal of Preventive Medicine that the previously reported changes in the proportions of more and less healthy foods purchased in the months after their program began have persisted up to two years after the labeling intervention was introduced.
NuPathe Inc., a specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced data from the pivotal Phase III trial of Zelrix™, a novel transdermal patch in clinical development for the treatment of acute migraine. Zelrix combines NuPathe's proprietary SmartRelief™ iontophoretic transdermal technology with sumatriptan, the most prescribed treatment for acute migraine in the United States.
A panel of experts convened by the RAND Corporation has recommended actions that communities around the United States should take to be better prepared to deal with bioterrorist attacks, pandemic flu outbreak and other large-scale public health emergencies.
› Verified 3 days ago
Jason Harlow Friesen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-683-1577 Fax: 541-344-6176 | |
Dr. Maxwell Yisheng Li, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-683-1577 Fax: 541-344-6176 | |
Kraig Warren Jacobson, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-683-1577 Fax: 541-344-6176 | |
Alice H Chou, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-683-1577 Fax: 541-344-6176 | |
Dr. Richard Otis Buck, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2201 Willamette St, Suite C, Eugene, OR 97405 Phone: 541-683-0730 Fax: 541-683-4411 | |
Lisa M Wheatley, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 920 Country Club Rd, Ste 200a, Eugene, OR 97401 Phone: 541-342-2134 Fax: 541-686-6021 |